A federal appeals court overturned the prior decision, ruling that Myriad Genetics could indeed hold patents to two genes that help forecast a woman's risk of breast cancer.

联邦上诉法院推翻了前面的判决，认为 Myriad Genetics 的确可以持有的两个帮助预测女性乳腺癌的基因专利。